Franklin Resources Inc Harpoon Therapeutics, Inc. Transaction History

Franklin Resources Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.6 - $1.41 $730 - $1,717	-1,218 Reduced 0.09%	1,323,286 $965,000
Q2 2022 Aug 11, 2022	SELL	$1.78 - $5.02 $602,795 - $1.7 Million	-338,649 Reduced 20.36%	1,324,504 $2.53 Million
Q1 2022 May 13, 2022	BUY	$3.54 - $8.08 $1.6 Million - $3.65 Million	451,142 Added 37.22%	1,663,153 $8.27 Million
Q4 2021 Feb 11, 2022	BUY	$5.69 - $7.83 $456,668 - $628,420	80,258 Added 7.09%	1,212,011 $9.15 Million
Q3 2021 Nov 12, 2021	SELL	$7.88 - $14.0 $45,325 - $80,528	-5,752 Reduced 0.51%	1,131,753 $8.94 Million
Q2 2021 Aug 13, 2021	BUY	$13.81 - $23.25 $869,546 - $1.46 Million	62,965 Added 5.86%	1,137,505 $15.8 Million
Q1 2021 May 13, 2021	BUY	$17.65 - $24.16 $19 Million - $26 Million	1,074,540 New	1,074,540 $22.5 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.